.svg){kind=small}
The protocol design is important as it dictates the way a study will be conducted.
Richmond Pharmacology’s Advanced Research Science Department has considerable experience in compiling Clinical Study Protocols according to ICH guidelines. Each protocol is developed in collaboration with the Sponsor in order to fulfil the trial requirements and objectives.
All protocols are written by Richmond Pharmacology’s Advanced Research Science team, with input from Richmond Pharmacology’s Research Physicians and Principal Investigators.
Our experienced Clinical Research Scientists will ensure your study design meets the specified end points by the most efficient method.
-min.jpg)
.jpg)
Latest news
Celebrating Clinical Trials Day 2023
May 19, 2023
This year, we will be celebrating Clinical Trials Day alongside our workforce, sponsors and industry colleagues.
Read moreFutureproofing early phase clinical research for the next generation of investigators.
March 20, 2023
Richmond Pharmacology’s experienced Principal investigators and Co-investigators recently gave expert feedback on the ICH M11 (CeSHarP) protocol template.
Read moreEvents
HFA Annual Meeting 2023
Saturday 20th May 2023 - Tuesday 23rd May 2023
Join Dr Taubel at the HFA Annual Meeting in Prague
View event
